Mon. May 25th, 2026
Spread the love

Central Bank of Nigeria (CBN) continuous delay in the roll out of the new flexible foreign exchange policy has resulted in a loss of N320billion by investors in conglomerates, multinational corporations and other big capitalized companies quoted on the Nigerian Stock Exchange, NSE.

The stock market had recorded a massive rally following the announcement by the Central Bank of Nigeria, CBN, of its plan to introduce a flexible foreign exchange regime.

However the bullish trend gave way to a massive bear run which brought down total market capitalization to N9.3 trillion, tuesday, from N9.7 trillion as at May 25, 2016, a day after the CBN announcement, with the blue chips accounting for about 80 per cent of the total losses.

Vanguard learnt that most companies in the real sector, especially the big brands have taken similar steps since 2015 to retain their market share and brand equity at huge cost.

For Unilever Nigeria Plc, the major drag to performance in its full year 2015 results released earlier this year was the massive jump in finance cost, up 66 per cent year-on-year despite 37.5 per cent drop in borrowings in the year.

According to financial analysts at Afrinvest West Africa, a Lagos based investment house, “Unilever remains highly levered as 62.9 per cent of its full year 2015 operational profit went into finance cost.   We still remain somehow bearish on the valuation of the company as the current macroeconomic challenges, most especially foreign exchange related operations are expected to take toll on overall performance”.

Berger Paints Nigeria Plc has attributed the drop in their financial performance for the first quarter ended March 31, 2016 to foreign exchange scarcity. The Managing Director, Mr Peter Folikwe, stated at the Nigerian Stock Exchange that”margin drop largely as a result of increase in raw material prices and scarcity of foreign exchange as we have to largely resort to local sourcing of raw materials at exorbitant price”.

Guinness Nigeria Plc had complained that the currency restrictions imposed by the Central Bank of Nigeria, CBN, were hindering it from procuring the foreign exchange needed to bring in raw materials. “Foreign currency capacity has been a major issue for us and that has put a strain on our business, in particular, liquidity has been a major challenge”, Managing Director, Peter Ndegwa, stated. Analysts attribute the decline in bottom line in the brewery sector to a weak Naira that significantly impacted on cost of sales since most of raw materials are imported to meet production.

Brewers are spending more to produce each unit of products as cost of sales ratio increased to 51.13 percent in 2015 from 45 percent the previous year, leading to total cost industry-wide of over N250 billion with Nigerian Breweries accounting for about N151 billion in 2015 and N40.2 billion in the first quarter of 2016.

The 11.85 per cent rise in cost recorded by Nigerian Breweries in the first quarter of 2016, according to analysts at FSDH Merchant Bank,  could be attributed to the rise in input costs. The cost of raw materials and consumables alone rose by 30.44 per cent to N24.56 billion from N18.83 billion in 2015.  Guinness Nigeria’s cost in 2015 was N62 billion.

The survey conducted by PricewaterhouseCoopers, PwC, showed that over 60 per cent of companies in Nigeria recorded huge declining sales/revenue as a result of the foreign exchange rationing policy.

The report, commissioned by the Lagos Chamber of Commerce and Industry, and unveiled in Lagos  by the President, LCCI, Dr. Nike Akande, and the Regional Managing Partner, West Africa, PwC, Mr. Uyi Akpata, revealed that 42 per cent of the companies had been implementing aggressive cost-cutting measures, while 18 per cent were already sacking staff.(Vanguard)

 

By admin

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.